| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |